PAI
KYTH

Palo Alto Investors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Palo Alto Investors’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,125,564
Closed -$84.4M – 48
2015
Q3 		$84.4M Sell
1,125,564
-164,728
-13% -$12.3M 4.06% 8
2015
Q2 		$97.2M Sell
1,290,292
-92,430
-7% -$4.95M 4.32% 9
2015
Q1 		$69.3M Buy
1,382,722
+260,838
+23% +$10.9M 3.43% 10
2014
Q4 		$38.9M Buy
1,121,884
+19,703
+2% +$688K 2.28% 14
2014
Q3 		$36.1M Buy
1,102,181
+152,222
+16% +$5.36M 2.7% 12
2014
Q2 		$36.5M Buy
949,959
+44,700
+5% +$1.56M 2.71% 12
2014
Q1 		$36M Buy
905,259
+4,700
+0.5% +$210K 2.97% 11
2013
Q4 		$33.6M Buy
900,559
+581,446
+182% +$24.1M 3.14% 12
2013
Q3 		$14.5M Buy
319,113
+232,912
+270% +$6.97M 1.52% 18
2013
Q2 		$2.33M Buy
+86,201
New +$1.97M 0.28% 27

Palo Alto Investors's KYTH Position: Q4 2015 in Review

Palo Alto Investors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 1,125,564 shares — an estimated $84.4M sold.

Palo Alto Investors first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $97.2M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Palo Alto Investors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Palo Alto Investors sold 1,125,564 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $84.4M.
  • Palo Alto Investors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Palo Alto Investors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $97.2M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Palo Alto Investors's 13F filing for Q4 2015, filed 16 Feb 2016.